en
Scientific article
Open access
French

Pneumologie : données sur l'asthme, la BPCO et la fibrose pulmonaire

Published inRevue médicale suisse, vol. 13, no. 544-545, p. 96-101
Publication date2017
Abstract

We chose, for this update on novelties in treatments for pulmonary disorders in 2016, to focus on advances in 3 pulmonary disorders : chronic obstructive pulmonary disease (COPD), asthma and IPF. For COPD, the contribution of inhaled glucocorticosteroids and roflumilast are revisited and the benefits obtained through endoscopic volume reduction procedures are clarified. In asthma and IPF, new molecules offer new hopes : a bettre control of exacerbations in asthma and a stabilisation or slowing of disease progression in IPF.

Keywords
  • Aminopyridines/therapeutic use
  • Asthma/drug therapy
  • Benzamides/therapeutic use
  • Cyclopropanes/therapeutic use
  • Humans
  • Idiopathic Pulmonary Fibrosis/therapy
  • Lung Diseases/therapy
  • Pulmonary Disease
  • Chronic Obstructive/drug therapy
  • Pulmonary Medicine/methods/trends
  • Therapies
  • Investigational/methods/trends
Citation (ISO format)
GIANELLA, Pietro et al. Pneumologie : données sur l’asthme, la BPCO et la fibrose pulmonaire. In: Revue médicale suisse, 2017, vol. 13, n° 544-545, p. 96–101.
Main files (1)
Article (Published version)
accessLevelPublic
Identifiers
ISSN of the journal1660-9379
344views
118downloads

Technical informations

Creation10/31/2018 12:04:00 PM
First validation10/31/2018 12:04:00 PM
Update time03/15/2023 1:53:00 PM
Status update03/15/2023 1:53:00 PM
Last indexation01/17/2024 4:11:48 AM
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack